Jonathan L. Moore
Impact in
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
- Oncology 14
- Cancer Immunotherapy and Biomarkers 4
- HER2/EGFR in Cancer Research 3
- CAR-T cell therapy research 2
- Chemokine receptors and signaling 2
-
- Immunotherapy and Immune Responses 7
- Co-authors
- Christopher C. Benz (2 shared papers)José Baselga (2 shared papers)Nancy T. Sklarin (2 shared papers)Andrew David Seidman (2 shared papers)Paul Peter Rosen (2 shared papers)Debu Tripathy (2 shared papers)Sharon A. Baughman (2 shared papers)I. Craig Henderson (2 shared papers)
- Journals
- British Journal of Cancer (7 papers)European Journal of Cancer (4 papers)Annals of Oncology (3 papers)Journal of Clinical Oncology (2 papers)British journal of surgery (2 papers)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Jonathan L. Moore
30 papers receiving 2.1k citations
Jonathan L. Moore's Hit Papers
Peers
Comparison fields: 5 of 89
- Oncology 1.4k
- Radiology, Nuclear Medicine and Imaging 692
- Immunology 372
- Cancer Research 214
- Hematology 165
Countries citing papers authored by Jonathan L. Moore
This map shows the geographic impact of Jonathan L. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan L. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan L. Moore more than expected).
Fields of papers citing papers by Jonathan L. Moore
This network shows the impact of papers produced by Jonathan L. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan L. Moore. The network helps show where Jonathan L. Moore may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan L. Moore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. Hit paper breakdown → | 1996 | 1186 |
| 2 | Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer. | 1999 | 246 |
| 3 | Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group. | 1990 | 161 |
| 4 | 1996 | 99 | |
| 5 | 1996 | 90 | |
| 6 | 2014 | 87 | |
| 7 | 1999 | 72 | |
| 8 | 1998 | 68 | |
| 9 | 1995 | 56 | |
| 10 | 2000 | 54 | |
| 11 | 2023 | 26 | |
| 12 | Low-dose cyclophosphamide and low-dose interleukin-2 for malignant melanoma. | 1989 | 21 |
| 13 | 2000 | 16 | |
| 14 | 2000 | 14 | |
| 15 | 1993 | 14 | |
| 16 | 2023 | 13 | |
| 17 | 2022 | 12 | |
| 18 | 1997 | 11 | |
| 19 | 1992 | 9 | |
| 20 | 1996 | 7 |
About Jonathan L. Moore
Jonathan L. Moore is a scholar working on Oncology, Immunology, Surgery, Pulmonary and Respiratory Medicine and Immunology and Allergy, having authored 30 papers that have together received 2.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), Esophageal Cancer Research and Treatment (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), HER2/EGFR in Cancer Research (3 papers), CAR-T cell therapy research (2 papers), Chemokine receptors and signaling (2 papers) and Gastric Cancer Management and Outcomes (2 papers). The work is most often cited by research in Oncology (1.4k citations), Radiology, Nuclear Medicine and Imaging (692 citations), Immunology (372 citations), Cancer Research (214 citations) and Hematology (165 citations). Jonathan L. Moore has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Christopher C. Benz, José Baselga, Nancy T. Sklarin, Andrew David Seidman, Paul Peter Rosen, Debu Tripathy, Sharon A. Baughman, I. Craig Henderson, Larry Norton and Clifford A. Hudis. Their work appears in journals such as British Journal of Cancer, European Journal of Cancer, Annals of Oncology, Journal of Clinical Oncology and British journal of surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.